Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Prospective Real-World Outcomes of Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 5834.

https://doi.org/10.1182/blood-2023-182800

Published: 2023

Journal Articles

Idarubicin Versus Daunorubicin Versus Mitoxantrone for Induction Chemotherapy in Acute Myeloid Leukemia: Patient Registration Study of Turkish Society of Hematology-Acute Myeloid Leukemia Working Group

Blood (2023) 142 (Supplement 1): 5838.

https://doi.org/10.1182/blood-2023-187351

Published: 2023

Journal Articles

Retrospective Analysis of Turkish AML Registry Database, on Behalf of AML Working Group of Turkish Society of Hematology

Blood (2022) 140 (Supplement 1): 8946–8947.

https://doi.org/10.1182/blood-2022-167639

Published: 2022

Journal Articles

Comparison of Graft-Versus-Host-Disease after the Bone Marrow Transplantation Versus Peripheral Blood As the Stem Cell Source for HLA Identical Sibling Transplants in Severe Aplastic Anemia: A Systematic Review and Meta-Analysis

Elifcan Aladag, Haluk Demiroglu, Hakan Goker

Blood (2022) 140 (Supplement 1): 12880–12881.

https://doi.org/10.1182/blood-2022-158473

Published: 2022

Journal Articles

ST2 and Rg3a As a Biomarker for Predicting of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Hakan Goker, MDPROF., Elifcan Aladag, MD, Yahya Buyukasik, MD, Nelson J. Chao, MD, Umit Akman, Bio., Haluk Demiroglu, MDPROF.

Blood (2019) 134 (Supplement_1): 5684.

https://doi.org/10.1182/blood-2019-121682

Published: 2019

Journal Articles

Comparison of the DONOR Lymphocyte Infusion and Second Allogeneic STEM-CELL Transplantation in the Treatment of First Hematological Relapse after Allogeneic STEM-CELL Transplantation in Adults with ACUTE Leukemia

Haluk Demiroglu, MDPROF., Elifcan Aladag, MD, Nelson J. Chao, MD, Yahya Buyukasik, MD, Hakan Goker, MDPROF.

Blood (2019) 134 (Supplement_1): 5698.

https://doi.org/10.1182/blood-2019-121599

Published: 2019

Journal Articles

Analysis of Elderly Patients with Chronic Myeloid Leukemia

Engin Kelkitli, MD, Hakan Goker, MD, Mehmet Turgut, MD, Memis Hilmi Atay, MD

Blood (2018) 132 (Supplement 1): 5449.

https://doi.org/10.1182/blood-2018-99-110222

Published: 2018

Journal Articles

Long-Term Results of Non- Fludarabine Versus Fludarabine-Based Conditioning Regimens in Severe Aplastic Anemia Patients

Elifcan Aladag, MD, Haluk Demiroglu, MDPROF., Rafiye Ciftciler, MD, Yahya Buyukasik, MDPROF., Nilgun Sayinalp, MDPROF., Salih Aksu, MDPROF., Ibrahim Celalettin Haznedaroglu, MDPROF., Osman Ozcebe, MDPROF., Nelson J. Chao, MD, Hakan Goker, MDPROF.

Blood (2018) 132 (Supplement 1): 5700.

https://doi.org/10.1182/blood-2018-99-110131

Published: 2018

Journal Articles

Echocardiographic Evaluation of Patients with Hodgkin and Non Hodgkin Lymphoma before and after Hematopoietic Stem Cell Transplantation

Engin Kelkitli, MD, Yahya Buyukasik, Haluk Demiroglu, MD, Levent Sahiner, Mufide Okay, Seda Aydin, Salih Aksu, Nilgun Sayinalp, MD, Ibrahim Celalettin Haznedaroglu, PhD, Fatma Tekin, Hakan Goker, MD

Blood (2017) 130 (Supplement 1): 5521.

https://doi.org/10.1182/blood.V130.Suppl_1.5521.5521

Published: 2017

Journal Articles

Multicenter Early Access Program Results from Turkey: Efficacy and Safety of Daratumumab Among Heavily Pretreated Relapse/Refractory Multiple Myeloma Patients

Meral Beksac, MD, Yildiz Aydin, MD, Hakan Goker, MD, Mehmet Turgut, MD, Sevgi Kalayoglu Besisik, Seckin Cagirgan, Tulin F Tuglular, MD, Filiz Vural, MD, Munci Yagci, MD

Blood (2017) 130 (Supplement 1): 5442.

https://doi.org/10.1182/blood.V130.Suppl_1.5442.5442

Published: 2017

Journal Articles

Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience

A. Burhan Ferhanoglu, MD, Murat Özbalak, Ayse Salihoglu, MD, Teoman Soysal, MD, ihsan Karadoğan, Semra Paydas, MD, Evren Ozdemir, MD, Birol Yıldız, Nuri Karadurmuş, Leylagül Kaynar, Zeynep Arzu Yeğin, Ezgi Pınar Özbalak, Gülsan Sucak, Vildan Ozkocaman, MD, Pervin Topçuoğlu, Muhit Ozcan, MD, Elif Birtas, Hakan Goker, MD

Blood (2017) 130 (Supplement 1): 5173.

https://doi.org/10.1182/blood.V130.Suppl_1.5173.5173

Published: 2017

Journal Articles

Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms

Adile Begum Bahcecioglu, Sezgin Etgul, Tuncay Aslan, Muruvvet Seda Aydın, Umit Yavuz Malkan, Mufide Okay, Evren Ozdemir, MD, Rafiye Ciftciler, Hakan Goker, MD, Yahya Buyukasik, MD

Blood (2016) 128 (22): 5483.

https://doi.org/10.1182/blood.V128.22.5483.5483

Published: 2016

Journal Articles

Prognostic Factors for Survival of Elderly Patients with Acute Myeloid Leukemia after Intensive Chemotherapy: Validation of 3 Popular Prognostic Models

Ebru Koca, MD, Aysun Halacoglu, MD, Umit Yavuz Malkan, MD, Deniz Arica, MD, Sema Karakus, MD, Hakan Goker, MD, Ibrahim C. Haznedaroglu, MD, Nilgun Sayinalp, MD, Yahya Buyukasik, MD

Blood (2014) 124 (21): 5332.

https://doi.org/10.1182/blood.V124.21.5332.5332

Published: 2014

Journal Articles

Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management

Gursel Gunes, MD, Umit Yavuz Malkan, MD, Salih Aksu, MD, Ibrahim Celalettin Haznedaroglu, MD, Yahya Buyukasik, MD, Nilgun Sayinalp, MD, Osman Ilhami Ozcebe, MD, Hakan Goker, MD, Haluk Demiroglu

Blood (2014) 124 (21): 5091.

https://doi.org/10.1182/blood.V124.21.5091.5091

Published: 2014

Journal Articles

Evaluation of Anti-Neoplastic Effects of a New Hemostatic Agent Ankaferd Blood Stopper on Myeloma Cell Line and Plasmocytoma Development in Balb/c Mice: Results of the First in Vitro and in Vivo Study

Ferit Avcu, MD, Mustafa Guner, Int Dr, Muammer Misirci, Int Dr, Pinar Elci, DDS, Mukerrem Safali, MD, Hakan Goker, MD, Ibrahim Celalettin Haznedaroglu, MD

Blood (2014) 124 (21): 5728.

https://doi.org/10.1182/blood.V124.21.5728.5728

Published: 2014

Journal Articles

Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission

Umit Yavuz Malkan, MD, Gursel Gunes, MD, Hakan Goker, MD, Eylem Eliacik, MD, Ayse Isik, MD, Nilgun Sayinalp, MD, Ibrahim Celalettin Haznedaroglu, MD, Haluk Demiroglu, Salih Aksu, MD, Osman Ilhami Ozcebe, MD, Muruvvet Seda Balaban, MD, Tuncay Aslan, MD, Sezgin Etgul, MD, Yahya Buyukasik, MD

Blood (2014) 124 (21): 2283.

https://doi.org/10.1182/blood.V124.21.2283.2283

Published: 2014

Journal Articles

Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration

Hakan Goker, MD, Eylem Eliacik, MD, Fevzi Altuntas, MD, Emre Tekgunduz, MD, Evren Ozdemir, MD, Ayse Isik, MD, Omur Kayikci, MD, Ali Hakan Kaya, MD, Salih Aksu, MD, Ibrahim C. Haznedaroglu, MD, Nilgun Sayinalp, MD, Haluk Demiroglu, Osman Ilhami Ozcebe, MD, Yahya Buyukasik, MD

Blood (2014) 124 (21): 5830.

https://doi.org/10.1182/blood.V124.21.5830.5830

Published: 2014

Journal Articles

Association Of Health Care Expenditure With Results Of Allogeneic HSCT For Adults With ALL: An Analysis From Acute Leukemia Working Party Of The EBMT

Sebastian Giebel, MD, Myriam Labopin, MD, Adalberto Ibatici, MD, Paul Browne, MD, Tomasz Czerw, Gérard Socié, MD, PhD, Ali Unal, MD, Slawomira Kyrcz-Krzemien, MD, Andrea Bacigalupo, MD, Hakan Goker, MD, Michael N Potter, MBBS, PhD, Grant McQuaker, MD, Dietrich Beelen, MD, Noel Milpied, MD, PhD, Antonio Campos, MD, Charles Craddock, MD DPhil, Mohamad Mohty, MD, PhD

Blood (2013) 122 (21): 2150.

https://doi.org/10.1182/blood.V122.21.2150.2150

Published: 2013

Journal Articles

Experience With BFM 95 Pediatric Regimen In Adult ACUTE Lymphoblastic Leukemia

Hakan Goker, MD, Eylem Eliacik, MD, Ayse Isik, MD., Ibrahim C. Haznedaroglu, MD, Prof, Nilgun Sayinalp, MD, Salih Aksu, MD, Osman Ozcebe, MD, Yahya Buyukasik, MD.

Blood (2013) 122 (21): 5015.

https://doi.org/10.1182/blood.V122.21.5015.5015

Published: 2013

Journal Articles

Comparison of Low Dose Total Body Irradiation (TBI)-Based Reduced Intensity Conditioning (RIC) Vs. Chemotherapy-Based RIC Prior to Allogeneic Stem Cell Transplantation (allo-SCT) From An HLA Identical Sibling Donor for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1): a Retrospective Analysis of 1200 Patients From the Acute Leukemia Working Party of EBMT.

Mohamad Mohty, MD, PhD, Myriam Labopin, Jeroen JWM Janssen, MD, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, J. J. Cornelissen, Noel-Jean Milpied, MD, Henrik Sengeloev, Didier Blaise, MD, Eefke Petersen, MD, Hakan Goker, John G. Gribben, Arnon Nagler, Vanderson Rocha, MD, PhD

Blood (2009) 114 (22): 1190.

https://doi.org/10.1182/blood.V114.22.1190.1190

Published: 2009

NARROW

Prospective Real-World Outcomes of Acute Myeloid Leukemia

Idarubicin Versus Daunorubicin Versus Mitoxantrone for Induction Chemotherapy in Acute Myeloid Leukemia: Patient Registration Study of Turkish Society of Hematology-Acute Myeloid Leukemia Working Group

Retrospective Analysis of Turkish AML Registry Database, on Behalf of AML Working Group of Turkish Society of Hematology

Comparison of Graft-Versus-Host-Disease after the Bone Marrow Transplantation Versus Peripheral Blood As the Stem Cell Source for HLA Identical Sibling Transplants in Severe Aplastic Anemia: A Systematic Review and Meta-Analysis

ST2 and Rg3a As a Biomarker for Predicting of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Comparison of the DONOR Lymphocyte Infusion and Second Allogeneic STEM-CELL Transplantation in the Treatment of First Hematological Relapse after Allogeneic STEM-CELL Transplantation in Adults with ACUTE Leukemia

Analysis of Elderly Patients with Chronic Myeloid Leukemia

Long-Term Results of Non- Fludarabine Versus Fludarabine-Based Conditioning Regimens in Severe Aplastic Anemia Patients

Echocardiographic Evaluation of Patients with Hodgkin and Non Hodgkin Lymphoma before and after Hematopoietic Stem Cell Transplantation

Multicenter Early Access Program Results from Turkey: Efficacy and Safety of Daratumumab Among Heavily Pretreated Relapse/Refractory Multiple Myeloma Patients

Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience

Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms

Prognostic Factors for Survival of Elderly Patients with Acute Myeloid Leukemia after Intensive Chemotherapy: Validation of 3 Popular Prognostic Models

Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management

Evaluation of Anti-Neoplastic Effects of a New Hemostatic Agent Ankaferd Blood Stopper on Myeloma Cell Line and Plasmocytoma Development in Balb/c Mice: Results of the First in Vitro and in Vivo Study

Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission

Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration

Association Of Health Care Expenditure With Results Of Allogeneic HSCT For Adults With ALL: An Analysis From Acute Leukemia Working Party Of The EBMT

Experience With BFM 95 Pediatric Regimen In Adult ACUTE Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only